Related Experiment Video
Updated: Mar 6, 2026
08:00
Defining the Program of Maternal mRNA Translation during In vitro Maturation using a Single Oocyte Reporter Assay
Published on: June 16, 2021
4.8K
Pyrrole-Based Macrocyclic Small-Molecule Inhibitors That Target Oocyte Maturation
Pethaiah Gunasekaran1, So-Rim Lee1, Seung-Min Jeong1
1Molecular Embryology Laboratory, Department of Animal Sciences, Chungbuk National University, Chung-Buk, 361-763, Republic of Korea.
Chemmedchem
|March 16, 2017
Summary
A new macrocyclic compound effectively inhibits Polo-like kinase 1 (PLK1) in oocytes, blocking maturation and embryonic development. This compound shows potential as a novel contraceptive agent by targeting PLK1.
Area of Science:
- Reproductive Biology
- Molecular Pharmacology
- Drug Discovery
Background:
- Polo-like kinase 1 (PLK1) is vital for oocyte maturation and meiosis.
- Previous peptidomimetic inhibitors targeting PLK1 have drawbacks.
- Development of small-molecule inhibitors is needed to overcome limitations of peptide-based drugs.
Purpose of the Study:
- To design and synthesize novel pyrrole-based small-molecule inhibitors of PLK1.
- To evaluate the efficacy of these inhibitors on porcine oocyte maturation.
- To identify a potent inhibitor for potential contraceptive development.
Main Methods:
- Synthesis of pyrrole-based macrocyclic compounds.
- Assessment of oocyte maturation rates in porcine and mouse models.
- Evaluation of embryonic blastocyst formation.
- Molecular modeling studies of compound-PLK1 interactions.
Main Results:
- Compound 4, a macrocyclic pyrrole derivative, exhibited potent PLK1 inhibitory activity.
- Compound 4 blocked porcine and mouse oocyte maturation and impaired spindle formation.
- Inhibition of PLK1 by compound 4 was confirmed through molecular modeling.
- Compound 4 demonstrated enhanced inhibition of embryonic blastocyst formation.
Conclusions:
- The macrocyclic compound 4 is a potent inhibitor of PLK1.
- Compound 4 effectively inhibits oocyte maturation and embryonic development.
- Compound 4 shows promise as a lead compound for developing new contraceptive agents.
Related Concept Videos
01:30Hormonal Control of the Ovarian Cycle
7.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.3K
02:02Meiosis II
51.1K
Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
51.1K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:07Oogenesis
70.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.8K
01:22Oogenesis
4.5K
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
4.5K